Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11026887 Methods of treating eosinophilic esophagitis

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 14, 2018
0
Date of Patent
June 8, 2021
0
Patent Application Number
16131812
0
Patent Citations
‌
US Patent 10471071 Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
‌
US Patent 10272037 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
‌
US Patent 10632069 Orally administered corticosteroid compositions
‌
US Patent 10105315 Methods of treating eosinophilic esophagitis
‌
US Patent 10176301 Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis
Patent Citations Received
‌
US Patent 12059494 Methods of treating eosinophilic esophagitis
0
‌
US Patent 11246828 Orally administered corticosteroid compositions
0
‌
US Patent 11260061 Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
‌
US Patent 11266598 Orally administered corticosteroid compositions
‌
US Patent 11684571 Methods of treating eosinophilic esophagitis
0
Patent Inventor Names
Gail M. Comer
0
Brian A. Meltzer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11026887
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0

Find more entities like US Patent 11026887 Methods of treating eosinophilic esophagitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo